Skip to main content

Table 2 Comparison of patients’ demographic background in the remission and the non-remission groups by univariate analysis

From: Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA

Measurements Remission group (n = 23) Non-remission group (n = 20) P-value
Age, year 39.2 ± 13.6 44.1 ± 16.2 ns
CAI score 8.9 ± 2.1 9.3 ± 2.3 ns
Duration of UC (year) 6.1 ± 7.3 8.6 ± 6.8 0.036
Interval between relapse and the 1st GMA (day) 27.7 ± 31.0 76.2 ± 88.1 0.016
PSL at the 1st GMA (mg/day) 18.7 ± 14.4 17.8 ± 10.5 ns
Cumulative PSL dose before 1st GMA (mg) 939.2 ± 1125.9 4578.5 ± 4752.6 0.006
WBC at the 1st GMA (/ul) 8304.1 ± 2432.3 9572.9 ± 2283.4 0.032
Hb at the 1st GMA (g/dl) 12.0 ± 1.7 12.7 ± 2.0 ns
CRP at the 1st GMA (mg/dl) 0.7 ± 1.0 0.7 ± 0.8 ns
  1. CAI, clinical activity index; CRP, C-reactive protein; GMA, granulocyte and monocte apheresis; Hb, haemoglobin; WBC, white blood cell; ns, not significant (p > 0.05).